European Board and College of Obstetrics and Gynaecology (EBCOG) position statement on the use of laser vaginal devices for treatment of genitourinary syndrome of menopause, vaginal laxity, pelvic organ prolapse and stress urinary incontinence

This publication has 13 references indexed in Scilit:

• Vaginal erbium laser treatment for stress urinary incontinence: A multicenter randomized sham‐controlled clinical trial
  International Journal of Gynecology & Obstetrics, 2023
• CO2 Laser and radiofrequency compared to a sham control group in treatment of stress urinary incontinence (LARF study arm 3). A randomized controlled trial
  International Urogynecology Journal, 2022
• Effect of Fractional Carbon Dioxide Laser vs Sham Treatment on Symptom Severity in Women With Postmenopausal Vaginal Symptoms
  JAMA, 2021
• Genitourinary syndrome of menopause: a systematic review on prevalence and treatment
  Menopause, 2021
• CO₂ laser and the genitourinary syndrome of menopause: a randomized sham-controlled trial
  Climacteric, 2020
• Can pelvic organ prolapse in postmenopausal women be treated with laser therapy?
  Climacteric, 2020
• Treatment for vaginal atrophy using microablative fractional CO2 laser: a randomized double-blinded sham-controlled trial
  Menopause, 2020
• Laser therapy for urinary incontinence and pelvic organ prolapse: a systematic review
  BJOG: An International Journal of Obstetrics & Gynaecology, 2020
• A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial
  Menopause, 2019
• Vaginal laxity: what does this symptom mean?
  International Urogynecology Journal, 2017